Latest News and Press Releases

Miata Intersects 96 m of 1.41 g/t gold in Near-Surface Gold System at Big Berg, Delivering Best Intercept to Date at the Sela Creek Gold Project, Suriname

Addgene and Plasmidsaurus announce that they have entered into a strategic partnership to scale sequencing for leading plasmid repository.

Tigris publication confirms positive results for primary and key secondary endpoints with 95.3% and 99.4% probability of benefit for PMX at 28-day and 90-day mortality After adjusting for baseline...

~ Delivered Record Annual Revenue with Full-Year Net PEDMARK® Product Sales of $44.6 Million, Representing 50% Year-Over-Year Growth, and Q4 2025 Net Product Sales of $13.8 Million, Representing 75%...

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

Dupixent, développé par Sanofi et Regeneron, a été approuvé au Japon comme premier médicament ciblé pour le traitement des adultes atteints de pemphigoïde bulleuse L’approbation chez les patients...

Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in moderate-to-severe patients was based on pivotal study results...

First approved treatment in Japan for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS)Approval is based on positive Phase III data from multinational and Japanese studies in patients...

Monday, March 30: Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody) for the seasonal prevention of Lyme disease  Wednesday, April 1: Animal and in vitro studies on...

New York City, NY, March 23, 2026 (GLOBE NEWSWIRE) --  As demand for Bitcoin casino no deposit bonuses continues to rise in 2026, players are becoming more selective about which offers are...